BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Bruker Announces Major Advances in CCS-Enabled 4D Proteomics at ASMS

  Bruker PaSER™ software now incorporates transformative CCS-enabled DIA-NN deep neural network learning with breakthrough dia-PASEF capabilities to identify

  November 2, 2021

   · 

  8 min read
• Business

  Moderna and Metagenomi Establish Collaboration to Develop Next-Generation In Vivo Gene Editing Therapeutics

  Moderna and Metagenomi Establish Collaboration to Develop Next-Generation In Vivo Gene Editing Therapeutics

  November 2, 2021

   · 

  6 min read
• Business

  Acorda Third Quarter 2021 Update: Webcast Scheduled for November 9, 2021

  Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a Webcast in conjunction with its third quarter 2021 update and financial results on Tuesday, November 9, at 4:30 p.m. ET.

  November 2, 2021

   · 

  4 min read
• Business

  Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs

  Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs

  November 2, 2021

   · 

  30 min read
• Biotech Beach

  Kura Oncology to Participate in Credit Suisse Healthcare Conference

  Kura Oncology, Inc. today announced its participation in the Credit Suisse 30th Annual Healthcare Conference.

  November 2, 2021

   · 

  1 min read
• Business

  GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2021

  GlycoMimetics, Inc. (Nasdaq: GLYC) today reported its financial results for the quarter ended September 30, 2021 and highlighted recent events. Cash and cash equivalents at September 30, 2021 were $101.9 million.

  November 2, 2021

   · 

  8 min read
• Biotech Bay

  Avellino Donates $25,000 to National Keratoconus Foundation to Support World Keratoconus Day and Disease Education

  Avellino Lab USA, Inc. (Avellino), in honor of World Keratoconus Day, today announced a $25,000 donation to the National Keratoconus Foundation (NKCF)

  November 2, 2021

   · 

  5 min read
• Business

  BioNet and Sartorius’ Company BIA Separations Collaborate on Production Process Development of mRNA Vaccines

  BioNet, a leading biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of Sartorius, a leading biochromatography development and manufacturing company, announced the successful development of an optimized mRNA manufacturing process.

  November 2, 2021

   · 

  2 min read
• Business

  Galecto Announces Clinical Collaboration with Roche for Phase 2 Trial of GB1211 in Combination with Atezolizumab in First Line Non-Small-Cell Lung Cancer

  Galecto, Inc. today announced that it has entered into a clinical trial supply agreement with Roche to explore the combination of GB1211 with Roche’s PD-L1 checkpoint inhibitor atezolizumab (Tecentriq®) in Galecto’s planned Phase 2a trial in non-small-cell lung cancer (NSCLC).

  November 2, 2021

   · 

  5 min read
• Drug Development

  The Texas Liver Institute Participating in RESPONSE, a Global Phase 3 Clinical Research Study Evaluating an Investigational Therapy for the Treatment of Primary Biliary Cholangitis (PBC)

  The Texas Liver Institute is enrolling participants into RESPONSE, a global phase 3 clinical research study evaluating the safety and efficacy of seladelpar

  November 2, 2021

   · 

  3 min read